Intrinsic Value of S&P & Nasdaq Contact Us

Akili, Inc. AKLI NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.25
+650.4%

Akili, Inc. (AKLI) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.

The consensus price target is $3.25 (low: $2.00, high: $4.50), representing an upside of 650.4% from the current price $0.43.

AKLI Stock — 12-Month Price Forecast

$3.25
▲ +650.40% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Akili, Inc., the average price target is $3.25, with a high forecast of $4.50, and a low forecast of $2.00.
The average price target represents a +650.40% change from the last price of $0.43.
Highest Price Target
$4.50
Average Price Target
$3.25
Lowest Price Target
$2.00

AKLI Analyst Ratings

Buy
4
Ratings
2 Buy
2 Hold
Based on 4 analysts giving stock ratings to Akili, Inc. in the past 3 months
Rating breakdown
Buy
2 50%
Hold
2 50%
50%
Buy
2 analysts
50%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message